Meiragtx Holdings Plc (MGTX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Meiragtx Holdings Plc  (NASDAQ: MGTX)


Meiragtx Holdings Plc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Meiragtx Holdings Plc's ROI in the second quarter of 2026?
Meiragtx Holdings Plc achieved a return on average invested assets (ROI) of 55.83 % in its second quarter of 2026 a new company high.

ROI has improved compared to -129.52% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 15 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3584 to 4088.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -26.43 % -55.85 % -49.06 % -42.39 % -18.63 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 339 69 122 37 145
Return On Investment (TTM) 55.83 % -129.52 % -96.1 % -119.38 % -81.96 %
MGTX's Overall Ranking # 4088 # 3584 # 3544 # 3614 # 3558
Seq. Investment Change TTM 51.93 % -21.69 % -15.9 % -26.48 % -8.82 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 79 -121 -114 -169 -158

MGTX Company Profile >> Back to MGTX Roi Comparisons >> See Annual MGTX Return On Investment



Return On Investment MGTX's Ranking
Within: No.
Industry # 3
Sector # 16
Overall # 4088

Return On Investment Statistics
High Average Low
55.83 %
-44.33 %
-129.52 %
(Jun 30 2026)   (Mar 31 2026)







Financial Statements
Meiragtx Holdings Plc's II. Quarter Investments $ 339 Millions MGTX's Balance sheet
Meiragtx Holdings Plc's II. Quarter Income $ 161 Millions Quarterly MGTX's Income Statement
MGTX's Income by Division See MGTX's Income by Division


MGTX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 122 209 260 236 310
Y / Y Investment Growth -41.68 % -19.52 % 9.95 % -23.71 % 12.69 %
Net Income in Millions -114 -148 -84 -130 -58
Y / Y Net Income Growth - - - - -
Annual Return On Investment -93.7 % -70.72 % -32.36 % -54.88 % -18.73 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MGTX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MGTX's Competitors
Subscribers only: Roi for Meiragtx Holdings Plc's Suppliers
Subscribers only: Return On Investment for MGTX's Customers

Other Ratios
MGTX's Roa MGTX's Inventory Turnover Ratio MGTX's Growth Rates MGTX's Dividend Statistics
MGTX's Profitability Ratios MGTX's Asset Turnover Ratio MGTX's Dividend Growth
MGTX's Roe MGTX's Valuation Ratios MGTX's Financial Strength Ratios MGTX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Pulmatrix Inc   108.83 %
Interpace Biosciences Inc   100.71 %
Rigel Pharmaceuticals Inc  89.00 %
Oncotelic Therapeutics Inc   87.35 %
Arbutus Biopharma Corp  85.89 %
Actinium Pharmaceuticals Inc  84.38 %
Exelixis Inc   82.05 %
Lensar Inc   75.31 %
Ironwood Pharmaceuticals inc   70.54 %
Oramed Pharmaceuticals Inc  68.90 %
Indivior Pharmaceuticals Inc   68.79 %
Rallybio Corporation  68.28 %
Fortress Biotech Inc   68.27 %
Earth Science Tech Inc   64.38 %
Meiragtx Holdings Plc  55.83 %
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %

Date modified: 2026-09-12T06:23:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.